Trial Profile

A Phase 1 Clinical Trials for IGX12

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 20 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs IGX 12 (Primary)
Indications Infertility
Focus Adverse reactions
Sponsors Igyxos

Most Recent Events

11 Mar 2025 According to an IGYXOS media release, company announced the successful completion of the single ascending dose (SAD) phase of its Phase I clinical trial evaluating IGX12 and has already initiated the multiple ascending dose (MAD) phase of the study for IGX12. The final results of the MAD are expected in Q4 2025.
11 Mar 2025 Results presented in the IGYXOS Media Release.
28 Dec 2023 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com